RWOD · Redwoods Acquisition Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | $321.3K | - | $271.1K | $238.7K | $0 | - | $0 | $0 | - | - |
| SG&A | $6.21M | - | $231.4K | $339.4K | $354.8K | - | $2.01M | $2.3K | $324.8K | - |
| Total Operating Expenses | $9.51M | - | $1.85M | $1.89M | $672.0K | - | $2.87M | $244.3K | - | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | ($9.51M) | - | ($1.85M) | ($1.89M) | ($1.59M) | - | ($2.87M) | ($395.6K) | ($342.8K) | - |
| Interest Expense | $553.9K | - | $1.18M | $1.76M | $553.9K | - | $45.0K | $20.2K | - | - |
| Income Tax | - | - | - | - | - | - | - | - | $49.1K | - |
| Net Income | ($13.86M) | - | ($2.90M) | ($4.09M) | ($2.23M) | - | ($126.5K) | ($451.6K) | ($123.2K) | - |
| EPS - Basic | ($0.15) | - | ($0.05) | ($0.12) | ($0.04) | - | ($0.18) | ($0.02) | - | - |
| EPS - Diluted | ($0.15) | - | ($0.05) | ($0.12) | ($0.04) | - | ($0.01) | ($0.03) | - | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.00M | $7.18M | $7.30M | $8.43M | $565.9K | $63.7K | $50.9K | $845.3K | $8.1K | $172.5K |
| Accounts Receivable | - | - | $339.3K | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $151.1K | $44.6K | $34.9K | $12.6K | $66.5K | $63.7K | $271.1K | $151.3K | - | - |
| Current Assets | $10.93M | $7.29M | $7.77M | $8.55M | $687.7K | $157.8K | $154.6K | $999.8K | $8.1K | $199.5K |
| Total Assets | $59.74M | $9.59M | $10.07M | $10.85M | $2.99M | $2.46M | $2.46M | $3.31M | $19.59M | $19.46M |
| Current Liabilities | $553.7K | $76.8K | $92.9K | $63.0K | $2.34M | $1.25M | $982.4K | $898.6K | $2.58M | $2.31M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $8.27M | $129.8K | $145.9K | $195.4K | $2.35M | $1.27M | $1.00M | $4.86M | $8.50M | $8.24M |
| Stockholders' Equity | $51.47M | $9.46M | $9.93M | $10.65M | $638.7K | $1.19M | $1.46M | ($1.55M) | ($7.73M) | ($7.35M) |
| Retained Earnings | ($34.97M) | ($21.11M) | ($19.79M) | ($16.89M) | ($12.80M) | ($10.56M) | ($8.50M) | ($5.54M) | ($7.73M) | ($7.35M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($4.97M) | - | - | - | ($1.55M) | - | - | - | ($376.5K) | - |
| Investing Cash Flow | ($365.3K) | - | - | - | - | - | - | - | ($70.0K) | - |
| Financing Cash Flow | $8.16M | - | - | - | $2.06M | - | - | - | $282.1K | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -23.2% | - | -28.7% | -37.7% | -74.8% | - | -5.1% | -13.6% | -0.6% | - |
| Return on equity | -26.9% | - | -29.2% | -38.4% | -349.8% | - | -8.7% | 29.1% | 1.6% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 19.74 | 95.01 | 83.69 | 135.74 | 0.29 | 0.13 | 0.16 | 1.11 | 0.00 | 0.09 |
| Quick ratio | 19.74 | 95.01 | 83.69 | 135.74 | 0.29 | 0.13 | 0.16 | 1.11 | 0.00 | 0.09 |
| Cash ratio | 18.06 | 93.49 | 78.59 | 133.91 | 0.24 | 0.05 | 0.05 | 0.94 | 0.00 | 0.07 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -17.2x | - | -1.6x | -1.1x | -2.9x | - | -63.9x | -19.6x | - | - |
| Equity multiplier | 1.16 | 1.01 | 1.01 | 1.02 | 4.68 | 2.07 | 1.69 | -2.13 | -2.53 | -2.65 |
| Liabilities / Assets | 0.14 | 0.01 | 0.01 | 0.02 | 0.79 | 0.52 | 0.41 | 1.47 | 0.43 | 0.42 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -499.4% | - | 35.4% | -378.5% | -363.0% | - | -882.4% | -10.5% | -5.2% | - |
| Net income growth (YoY) | -520.3% | - | -2189.5% | -806.3% | -1713.0% | - | - | -194.1% | - | - |
| EPS growth (YoY) | -275.0% | - | -400.0% | -300.0% | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 7958.2% | 698.4% | 579.7% | - | - | - | - | 74.3% | -58.4% | -81.7% |
Peer comparison
Same SIC group: Biological Products, (No Diagnostic Substances)
Comparing Redwoods Acquisition Corp. against the 5 most active filers in the same SIC group.